Most Recent
IP Australia puts kibosh on extension for Bayer’s contraceptive patent
IP Australia has quashed an extension for a patent covering a Bayer oral contraceptive, saying the extension should have been calculated based on a drug that was included on the Australian Register of Therapeutic Goods at an earlier date.
Novartis unit Sandoz sues to revoke Bayer’s patents for blood thinner Xarelto
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.
Monster Energy takes PepsiCo to court over ‘Monster Munch’ trade mark
Monster Energy has instituted court proceedings against PepsiCo after failing to block the beverage giant from registering the 'Monster Munch' trade mark for the iconic British kids corn snack in Australia.
Energy Beverages files ‘Mother’ of an appeal against trade mark decision
A high-energy trade mark dispute has gone to the Federal Court after the maker of Mother energy drinks lost its bid before IP Australia to prevent a Victoria-based company from registering Kangaroo Mother as a trade mark for beverages.
‘Why cannot our own creations also create?’: AI can be inventor on patent, court finds
A judge has found artificial intelligence can be named as the inventor on a patent application, setting aside an IP Australia finding that allowing a machine to be considered an inventor would render the Patents Act incapable of "sensible operation".
Instagoods takes trade mark fight with Instagram to Federal Court
Retail tech and dating start-up Instagoods has appealed a successful challenge of its Instadate trade mark registration by social media giant Instagram.
‘Buttermite’ deceptively similar to Vegemite trade mark, IP Australia delegate says
Vegemite maker Bega Cheese has won a challenge to an inventor's bid to register 'Buttermite' as a trade mark for a breakfast spread.
Full Court upholds Sequenom’s win in patent battle over prenatal genetic tests
The Full Federal Court has upheld US biotech company Sequenom's  patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic's argument that the patent merely described a way to extract incorporeal genetic information.
Janssen triumphs again in battle to protect HIV drug patents
Juno Pharmaceuticals has backed away from its plans to launch a generic version of HIV drug Prezista in Australia after being hit with a patent lawsuit by Janssen, becoming the second generic drug maker to capitulate to the Johnson & Johnson-owned company's demands.
Can artificial intelligence be named inventor of a patent? Federal Court to rule
The Federal Court is set to determine whether artificial intelligence can be the inventor of a patent, after an AI pioneer filed a challenge to an IP Australia finding that allowing a machine to be considered an inventor would render the Patents Act incapable of "sensible operation".